Monday, 20 April 2009
(Hosted by Olswang)
(Co-organiser: Asia-Pacific Technology Network)
(Co-organiser: London Biotechnology Network)
Chair
Speakers:
Background
Low operating costs coupled with strong capabilities in the healthcare, engineering and IT disciplines favourably positions India's medical technology industry. Indian companies have proven track records in delivering cost effective manufacturing and IT services to international companies. These players are now actively seeking to move up the value chain to innovative and sophisticated services and products. Furthermore India's rapidly increasing consumption of healthcare services makes it an exciting market for international companies looking for growth opportunities. Our speakers with expertise in the IT, medical devices and innovation sectors will share their experiences and discuss approaches that would contribute to accelerated growth.
Location: Olswang, 90 High Holborn, London, WC1V 6XX (nearest tube station Holborn)
Timing: 17:30 - 1930 (Please arrive 15 minutes early to register)
Pricing:
Background
Dr Nermeen Y. Varawalla, MD, DPhil (Oxon), MBA President & CEO ECCRO
Dr Nermeen Varawalla is recognised to be an industry expert in the utilisation of emerging countries for global clinical trials and leads ECCRO – the pan Emerging Country Contract Research Organisation. At Accenture’s UK Health & Life Sciences Business Consulting Practice, working with pharmaceutical and biotechnology companies on drug development strategies, processes and systems Nermeen became an enthusiast for including emerging countries in global clinical development programmes. She left Accenture to set up PerinClinical, a niche India focussed CRO that she subsequently sold to PRA International. Nermeen was a Vice President at PRA International - a global CRO with over 3200 employees for five years during which time she held a number of leadership roles, most notably establishing and growing PRA’s operations in India. Nermeen received her medical training at the KEM group of hospitals, Mumbai, India. She was awarded the Rhodes Research Fellowship to the University of Oxford where she conducted her doctoral research in Molecular Genetics. Nermeen practised as a specialist at two of the UK’s leading NHS Hospitals. She then obtained her MBA at INSEAD. In recognition of her expertise in the globalisation of clinical trials, Dr Varawalla is frequently invited to speak at industry conferences. In addition she is a regular contributor to industry trade and peer reviewed publications and serves on the editorial board of the Journal of the Institute of Clinical Research, India and the Journal for Clinical Studies, UK. Nermeen is well conversant with the Indian biomedical sector and in her capacity as Chair, OperationIndia serves as an advisor to international organisations.